Lisata Therapeutics
LSTA
32 hedge funds and large institutions have $12.9M invested in Lisata Therapeutics in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 7 closing their positions.
288% more capital invested
Capital invested by funds: $3.32M → $12.9M (+$9.56M)
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
0.05% less ownership
Funds ownership: 0.8% → 0.75% (-0.05%)
4% less call options, than puts
Call options by funds: $2.67M | Put options by funds: $2.79M
3% less funds holding
Funds holding: 33 → 32 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.98M |
| 2 |
BlackRock
New York
|
+$2.04M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$980K |
| 4 |
Renaissance Technologies
New York
|
+$837K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$549K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$345K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$296K |
| 3 |
Two Sigma Advisers
New York
|
-$109K |
| 4 |
VF
Virtu Financial
New York
|
-$75K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$69.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KFS
26
Kelly Financial Services
Braintree,
Massachusetts
| $19 | – | – | – |
|
|
RE
27
RBC Europe
London,
United Kingdom
| $19 | – | – | – |
|
|
AFM
28
Anson Funds Management
Dallas,
Texas
| – | -$345K | -16,072 | Closed |
|
|
29
Acadian Asset Management
Boston,
Massachusetts
| – | -$296K | -13,815 | Closed |
|
|
VF
30
Virtu Financial
New York
| – | -$75K | -3,507 | Closed |
|
31
Squarepoint
New York
| – | -$30K | -1,376 | Closed |
|
32
Simplex Trading
Chicago,
Illinois
| – | -$30.9K | -1,021 | Closed |
|
33
UBS Group
Zurich,
Switzerland
| – | -$13.1K | -432 | -100% |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | -$7K | -331 | Closed |
|
35
Group One Trading
Chicago,
Illinois
| – | -$4.82K | -159 | Closed |
|
36
Citigroup
New York
| – | -$182 | -6 | -46% |
|
LSTA Hedge Fund Activity: Q1 2021 in Review
32 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q1 2021, worth a combined $12.9M — up 288% from $3.32M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of LSTA and 6 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 11 added.
The largest buyer was Vanguard Group, adding an estimated $4.98M. The largest seller was Anson Funds Management, exiting entirely with an estimated $345K sold.
- 32 institutional investors held Lisata Therapeutics (LSTA) as of Q1 2021, down from 33 in Q4 2020.
- Funds reported $12.9M of Lisata Therapeutics stock for Q1 2021, up 288% quarter-over-quarter.
- 6 funds opened new Lisata Therapeutics positions in Q1 2021 and 7 closed out, a net change of -1 holder.
- The largest Lisata Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $4.98M added.
- The largest Lisata Therapeutics seller in Q1 2021 was Anson Funds Management, an estimated $345K sold.
Based on aggregated 13F filings for Q1 2021.